Design Therapeutics Inc (DSGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 0 | 226 |
| Gross Profit | N/A | N/A | N/A | N/A | 226 |
| Operating Expenses | 62,383 | 78,190 | 67,593 | 35,831 | 8,556 |
| Operating Income | -62,383 | -78,190 | -67,593 | -35,831 | -8,330 |
| Other Income | 12,795 | 11,328 | 4,285 | 298 | 50 |
| Pre-tax Income | -49,588 | -66,862 | -63,308 | -35,533 | -8,280 |
| Net Income Continuous | -49,588 | -66,862 | -63,308 | -35,533 | -8,280 |
| Net Income | $-49,588 | $-66,862 | $-63,308 | $-35,533 | $-8,280 |
| EPS Basic Total Ops | -0.88 | -1.19 | -1.14 | -0.77 | -0.52 |
| EPS Basic Continuous Ops | -0.88 | -1.19 | -1.14 | -0.77 | -0.52 |
| EPS Diluted Total Ops | -0.88 | -1.19 | -1.14 | -0.77 | -0.52 |
| EPS Diluted Continuous Ops | -0.88 | -1.19 | -1.14 | -0.77 | -0.52 |
| EPS Diluted Before Non-Recurring Items | -0.88 | -1.19 | -1.14 | -0.77 | N/A |
| EBITDA(a) | $-67,985 | $-83,737 | $-68,583 | $-35,779 | $-8,396 |